In women, after menopause, there is a fall in hormone levels wBlood Pressure Mhich leads to uncomfortable conditions like hot flashes, vaginal dryness and sometimes osteoporosis and heart conditions and also reduces the risk of diabetes by 30% in younger women. HRT's main purpose is to replace hormones that your body can no longer produce which is one of the reasons why it is the most efficient treatment for menopause.
Estrogen Therapy is mainly recommended to women who have had a hysterectomy and experiencing the menopause symptoms. This is mainly due to the fact that though Estrogen helps during pregnancy, it also controls how your body controls calcium and raises good cholesterol in the blood. Estrogen/Progesterone/Progestin Therapy is prescribed to women who still have their uterus owing to the fact that taking Estrogen without Progesterone raises the risk of cancer of the endometrium, the lining of the uterus.
The DROC Analysis contains some of the factors that have major effects on the market dynamics be it positive or negative. Few factors analysed in the section are growing awareness on post-menopausal hazards, reimbursement policies, novel formulations, rise in unmet medical needs which require the employment of hormone therapy as well as benefits like lower risk of fractures. However, based on research studies, hormone replacement therapy can cause severe side effects, such as bleeding, breast tenderness or enlargement, bloating, mood changes, headaches, and nausea, risk of breast cancer, heart disease, and stroke. Along with this, high cost of therapy is limiting its reach to middle class people. Further, women with high susceptibility to coronary diseases are advised to stay away from hormone replacement therapy thereby decreasing the size of target audience.
The therapy is segmented based on hormone and route of administration and studied for a deep-level understanding of the Hormone Replacement Therapy market. Each sub segment is accompanied with Market Size Estimations and Y-o-Y Forecasts as well.
• By Hormone Type o Estrogen Replacement Therapy o Growth Hormone Replacement Therapy o Thyroid Replacement Therapy o Others
• By Route of Administration o Oral o Parenteral o Transdermal o Others
North American Market is studied in geographic perspective by segregating the market shares between USA and Canada. USA dominates the market in the region owing to the economic conditions, awareness among women and government reimbursement policies present.
As per the report, some of the key players operating in the North America hormone replacement industry are Novartis, Abbott Laboratories, Pfizer, Mylan Laboratories, F. Hoffmann-La Roche, Merck & Co., Amgen, Eli Lily, Bayer, Novo Nordisk, Wyeth, Hisamitsu Pharmaceutical Co. Inc.
Scope of the North America Hormone Replacement Therapy Market:
• Regional and country-level analysis that provides an innate perspective of USA and Canada Market to that of the North American region
• To detect major focus areas of industrial growth Segment-level analysis on basis of type, therapeutics, end-user along with market size forecasts and y-o-y estimations are provided
• Detailed explanation of major drivers, restraints, opportunities, and challenges (DROC) that affect the market and impact the ever-shifting market dynamics
• PESTLE and Porter’s Five Forces Analyses that examine the macro & micro environmental factors such as political influence, technological prowess, industry rivalry to name a few.
• An extensive listing of major market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and analyst overview to study and sustain the market environment
• mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies all rolled out into Competitive landscape
• Expertly devised Market Outlook comprising the Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
About Market Data Forecast: The publisher of this report is Market Data Forecast whose forte lies in Market Research and Business Intelligence. Handling both individual and corporate clients across multiple business domains they offer syndicated/customized research to suit the client’s research objective. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering North America among other regions of the global market as well. For more info kindly visit, www.marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
